Previous close | 0.2100 |
Open | 0.2000 |
Bid | 0.2200 x N/A |
Ask | 0.2400 x N/A |
Day's range | 0.2000 - 0.2100 |
52-week range | 0.2000 - 0.2100 |
Volume | |
Avg. volume | 0 |
Market cap | 19.951M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
REGINA, Saskatchewan, June 06, 2024 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (PTN.P-TSX-V), is pleased to announce that, further to its news releases dated April 20, 2023, July 26, 2023, August 31, 2023, October 10, 2023, January 22, 2024, February 21, 2024, March 22, 2024 and May 27, 2024, it has completed: (a) the acquisition (the “Acquisition”) of 75% of the outstanding shares of Saskatoon Family Pharmacy Ltd. (“SFP”), to form the “Resulting Issuer”; and (b)
Final Long Form Prospectus Accessible on SEDAR+REGINA, Saskatchewan, May 27, 2024 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (PTN.P-TSX-V), a capital pool company under the rules of the TSX Venture Exchange (the “TSXV”), is pleased to announce that, further to its news releases dated April 20, 2023, July 26, 2023, August 31, 2023, October 10, 2023, January 22, 2024, February 21, 2024 and March 22, 2024, it has obtained a receipt for the final long form prospectus (t
REGINA, Saskatchewan, March 22, 2024 (GLOBE NEWSWIRE) -- PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (PTN.P-TSX-V), a capital pool company under the rules of the TSX Venture Exchange (the “TSXV”), is pleased to announce that, further to its news releases dated April 20, 2023, July 26, 2023, August 31, 2023, October 10, 2023 and February 21, 2024, it has obtained a receipt for the preliminary long form prospectus (the “Prospectus”) filed with the securities regulatory authorities in each